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Cohort profile
AbstrACt
Purpose REtard de Croissance Intra-uterin et PALudisme 
(RECIPAL) is an original preconceptional cohort designed 
to assess the consequences of malaria during the first 
trimester of pregnancy, which is a poorly investigated 
period in Africa and during which malaria may be 
detrimental to the fetus.
Participants For this purpose, a total of 1214 women of 
reproductive age living in Sô-Ava and Akassato districts 
(south Benin) were followed up monthly from June 2014 
to December 2016 until 411 of them became pregnant. 
A large range of health determinants was collected 
both before and during pregnancy from the first weeks 
of gestation to delivery. Five Doppler ultrasound scans 
were performed for early dating of the pregnancy and 
longitudinal fetal growth assessment.
Findings to date Pregnant women were identified at a 
mean of 6.9 weeks of gestation (wg). Preliminary results 
confirmed the high prevalence of malaria in the first 
trimester of pregnancy, with more than 25.4% of women 
presenting at least one microscopic malarial infection 
during this period. Most infections occurred before six 
wg. The prevalence of low birth weight, small birth weight 
for gestational age (according to INTERGROWTH-21st 
charts) and preterm birth was 9.3%, 18.3% and 12.6%, 
respectively.
Future plans REtard de Croissance Intra-uterin et 
PALudisme (RECIPAL) represents at this time a unique 
resource that will provide information on multiple 
infectious (including malaria), biological, nutritional 
and environmental determinants in relation to health 
outcomes in women of reproductive age, pregnant women 
and their newborns. It will contribute to better define 
future recommendations for the prevention of malaria in 
early pregnancy and maternal malnutrition in Africa. It 
confirms that it is possible to constitute a preconceptional 
pregnancy cohort in Africa and provides valuable 
information for researchers starting cohorts in the future.
IntroduCtIon 
Malaria in pregnancy is associated with a wide 
range of deleterious effects in women and 
their offspring. In Sub-Saharan African (SSA) 
countries, preventive strategies are based 
on long-lasting insecticide-treated bed nets 
(LLITNs) and intermittent preventive treat-
ment in pregnancy (IPTp). IPTp consists in the 
administration of sulfadoxine–pyrimethamine 
(SP) at each antenatal care (ANC) visit from 
the second trimester of pregnancy onwards.1 
LLITN are distributed at the first ANC visit, 
which generally occurs around 4–5 months 
of pregnancy.2 Therefore, pregnant women 
remain unprotected or insufficiently protected 
during the first months of pregnancy and 
particularly during the first trimester. However, 
this period may be a high-risk period for the 
fetus if pregnancy-associated malarial parasites 
strengths and limitations of this study
 ► A unique cohort combining highly detailed, 
high-quality health-related information on the 
pregnancies of approximately 400 women recruited 
in the preconception period, with a substantial 
related biobank of plasmas, placental and other 
samples.
 ► Preconceptional design allowing the early 
identification and follow-up of pregnant women: 
screening of women for both microscopic and 
submicroscopic malaria from the first weeks of 
pregnancy;  accurate estimation of gestational 
age by using early obstetrical ultrasound scan and 
collection of some important factors influencing fetal 
growth such as prepregnancy nutritional status and 
gestational hypertensive disorders.
 ► Collection of valuable information for the 
implementation of future preconceptional cohorts 
in Africa.
 ► High attrition in the preconceptional cohort, with 
a possible impact on the external validity of some 
findings.
 ► Reduced sample size at delivery due to a high 
proportion of spontaneous abortion, with a possible 
lack of power for analyses on birth outcomes.
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accumulate into the placenta during trophoblast differen-
tiation and vascular remodelling of the uterus.3 4 Impaired 
placentation may then contribute to fetal growth restriction 
and low birth weight (LBW).
Few studies have investigated malaria in early pregnancy, 
and while some have shown an adverse effect on birth 
outcomes, this has not been consistent.5 In Burkina Faso 
and in Benin, malarial infection in the first trimester6 or 
before 4 to 5 months of pregnancy7 8 has been associated 
with a higher risk of LBW or a decrease in birth weight. 
Conversely, such association was not reported in Uganda 
and Malawi,9 10 but the number of women screened in the 
first trimester was low in these two studies. One of the prob-
lems in interpreting this existing literature relates to the 
challenges of recruiting women early in pregnancy; most 
of the studies were not designed to assess the consequences 
of malaria early in pregnancy and therefore women were 
generally recruited late in the first trimester, which may 
lead to misclassification errors and underestimation of 
exposure. Besides, using LBW as a proxy for fetal growth 
restriction (FGR) can lead to the overestimation of FGR 
prevalence and possible bias when estimating the effect 
of malaria. Finally, maternal nutrition is one of the main 
factors influencing fetal growth in developing countries.11 
Therefore, adjusting for this factor when assessing the 
effect of early malaria on FGR is important. As well, a recent 
study has suggested a higher risk of FGR due to malaria in 
undernourished women.12
The REtard de Croissance  Intra-uterin et PALudisme 
(RECIPAL) study aimed to assess the effect of malaria (both 
microscopic and submicroscopic) in the first trimester of 
pregnancy on both the mother and the fetus, with a focus 
on fetal growth, by following a cohort of pregnant women 
recruited before conception. Moreover, it also aimed at 
assessing the influence of the woman’s nutritional status in 
the relationship between malaria in early pregnancy and 
birth outcomes.
Cohort desCrIPtIon
study setting
The study cohort is currently conducted in the districts 
of Sô-Ava and Abomey-Calavi, located in Southern Benin 
(figure 1). Women's recruitment has been completed by 
Figure 1 Geographical location of Sô-Ava and Abomey-Calavi districts and of the 35 villages of the RECIPAL study, Southern 
Benin, 2014–2017. RECIPAL, REtard de Croissance Intra-uterin et PALudisme.
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December 2016, and pregnancy follow-up is still ongoing. 
In the area, malaria is hyperendemic with a mean entomo-
logical inoculation rate of 2.1 infected anopheles bites/
person/100 nights.13 The main mosquito vectors of malaria 
are Anopheles gambiae ss and Anopheles funestus.14 Four 
subdistricts (Sô-Ava, Vekky and Houedo in Sô-Ava District 
and Akassato in Abomey-Calavi District) were selected for 
the study according to the population density and mean 
number of ANC visits and deliveries per month in the four 
main public maternity clinics of Sô-Ava and Abomey-Calavi 
districts. In these four subdistricts, the population size 
was estimated to 124 994 people in 2013, including 17.4% 
(21 779) women of reproductive age (WRA).15 Thirty-five 
out of a total of 36 villages were then selected for the study 
according to their proximity to the maternity clinics.
study design, subject identification, recruitment and 
enrolment procedures
Briefly, WRAs were recruited at community level and 
followed monthly for a maximum period of 24 months until 
becoming pregnant. They constituted the RECIPAL initial 
cohort. The subsample of women who became pregnant 
was then followed up monthly at the maternity clinic from 
early pregnancy to delivery. They constituted the RECIPAL 
final cohort.
A sample size of 466 births was estimated sufficient to 
evidence a two-fold OR for the association between malaria 
and poor birth outcomes,4 assuming a prevalence of 25% 
of women with microscopic malaria in the first trimester 
of pregnancy and 30% of poor birth outcomes (LBW, 
small-for-gestational age (SGA), preterm birth (PTB) or 
stillbirth)8 16 17 with an 80% power, significant level at 0.05. 
We estimated that following 2000 WRA (initial cohort) 
would have allowed identifying 510 pregnant women (final 
cohort) during a planned 18-month period for recruit-
ment in the initial cohort (based on a total fertility rate of 
200/1000/year in Benin (http:// esa. un. org/ unpd/ wpp/ 
index. htm)) and allowing 15% of loss to follow-up after 
recruitment in the initial cohort.
After explanation of the study to the local political and 
administrative authorities, three concomitant procedures 
were used to recruit WRA. First, repeated sensitisation 
events were organised in each of the 35 selected villages for 
presenting the study to all inhabitants. If interested, women 
were invited to register with the head of the community 
and were visited at home the day after for their inclusion. 
That procedure constituted the main way of recruitment 
throughout the study. Second, leaders of the community, 
religious authorities and mass media were involved to 
help us mobilise women during public meetings (masses, 
women’s association meetings, etc). The last way of recruit-
ment consisted of going door to door to identify eligible 
and interested women with the assistance a network of 
community health workers (more details are provided in 
the online supplementary file S1).
To be included, women had met the following criteria: 
negative urinary pregnancy test, 18 to 45 years old, no 
current contraception, no previous fecundity issues, 
willingness to become pregnant, no planned travel for 
more than 2 months within the next 18 months, accep-
tance of RECIPAL protocol and signed written informed 
consent. Both oral and written communication was used 
for providing information on the project to the women 
and their husbands. The consent form was translated into 
the local language for women who were illiterate.
From June 2014 to December 2016, 1302 WRA were 
willing to participate in the study. Among them, 1214 
(93.2%) met the inclusion criteria and were recruited, 
88 (6.8%) were not included mainly because of a positive 
urinary pregnancy test at inclusion (63.6%) or past infer-
tility issues (14.8%). Based on both the 2013 national census 
and the 2011–2012 Demographic Health Survey (DHS-IV) 
in Benin, we estimated that women included in the project 
represented 6% of the total number of WRA living in the 
study area. Compared with women included in Dansou et 
al study,18 which used individual data of a representative 
sample of WRA included in the Beninese DHS-IV, WRA 
included in RECIPAL had a higher level of poverty. The 
other sociodemographic characteristics such as age, educa-
tion level, household wealth, gravidity and media exposure 
were, however, similar (online supplementary file S2).
RECIPAL study was approved by the ethics committees of 
the Institut des Sciences Biomédicales Appliquées (ISBA) in 
Benin and from the National Research Institute for Sustain-
able Development in France as well as by the Ministry of 
Health in Benin.
Cohort follow-up
Preconceptional follow-up
After enrolment, WRAs were visited at home monthly by 
specifically trained investigators assisted by local commu-
nity health workers. Follow-up consisted mainly of recording 
the first day of last menstrual period (LMP) and performing 
a urinary pregnancy test every month. To minimise the risk 
of loss of confidentiality during the tracking of women for 
follow-up, the study team was instructed to speak only to 
people—including family members—to whom women 
have granted them permission to speak. After 12 months, 
women who were still followed received medical advices to 
help conceive, and they were invited to attend the mater-
nity clinic for a medical examination in case of symptoms 
of genital infection. After 24 months, the follow-up ended 
and women who did not conceive were invited to attend a 
gynaecologist for fertility issues assessment. More details on 
the follow-up procedures have been provided in the online 
supplementary file S3 .
Gestational follow-up
Once pregnant, women were followed up at the mater-
nity clinic for monthly ANC visits. In addition, they were 
encouraged to attend the maternity clinic any time in case 
of any symptoms. Both the maternity staff (for usual ANC 
follow-up and clinical examination) and study investigators 
(for all specific issues related to RECIPAL) were involved 
in women’s follow-up. Throughout the study, women were 
offered free transport to the maternity clinic; in Sô-Ava 
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District, a free river shuttle was set up. At 37 weeks of gesta-
tion (wg), women were visited at home weekly and trans-
portation to the study maternity clinic was scheduled for 
delivery.
According to Beninese national recommendations, a kit 
including iron and folic acid tablets for 1 month, meben-
dazole for deworming, the first dose of SP for IPTp and a 
LLITN was given to each pregnant woman at the first ANC 
visit. The maternity staff was encouraged to administer at 
least three doses of IPTp from the second trimester onwards 
as recommended by the Beninese National Malaria Control 
Programme, as well as iron and folic acid supplementa-
tion throughout the pregnancy. RECIPAL women bene-
fited from free management of any diseases related to the 
pregnancy—detected either as part of RECIPAL follow-up 
or during unscheduled visits, free ANC visits and delivery. 
Women infected with malaria were treated with quinine in 
the first trimester of pregnancy and artemether–lumefan-
trine from the second trimester.
Infant follow-up
The infant follow-up was not initially planned as part of the 
RECIPAL project. It is currently carried out as part of the 
SEPSIS project (bioMérieux-funding, UMR216/9198 coor-
dination), which aims to assess immune dysfunctions associ-
ated with the risk of sepsis in preterm and growth-restricted 
newborns as well as in those exposed to malaria in utero. 
All infants born from the RECIPAL women from April 2016 
have been included and followed until 3 months of age.
Cohort attrition
Among the 411 pregnant women, 207 (50.4%) have 
already delivered, 16.5% (68/411) had a spontaneous 
abortion (n=68) or a non-viable pregnancy (n=2), 62 did 
not complete the study because of informed consent with-
drawal (45/411, 10.9%) or migration (17/411, 4.1%) 
and 72 women are still followed (figure 2). Spontaneous 
abortions, informed consent withdrawals and migrations 
occurred at 8.9 (±3.9), 13.2 (±8.1) and 14.2 (±8.6) wg in 
average (SD), respectively. More details on the reasons for 
cohort attrition are provided in the online supplementary 
file S4 .
Figure 2 presents the flowchart diagram of the study. 
Among the 1214 WRA enrolled in the initial cohort, 411 
(33.9%) became pregnant, 359 (29.6%) completed the 
follow-up without conceiving and 444 women (36.6%) did 
not complete the study mainly because of informed consent 
withdrawal (272/444) or migration outside the study 
area (138/444) that occurred after 5.2 and 6.3 months of 
follow-up in average, respectively.
data collection
Preconceptional data
Demographic, socioeconomic and household characteris-
tics were collected at inclusion (table 1). At this occasion, 
screening for malaria, urinary schistosomiasis, Chlamydia 
trachomatis and Neisseria gonorrhoeae was performed. Haemo-
globin (Hb) and markers of inflammation levels were 
determined. The first day of LMP was recorded and a 
urinary pregnancy test (One-Step; International Holding, 
Germany) was performed each month. Anthropometric 
measurements were collected every 3 months, and dietary 
intakes were assessed twice during follow-up.
Gestational data
At each ANC visit, clinical, anthropometric and obstet-
rical data, as well as LLITN use, IPTp administration, 
alcohol consumption and iron, folic acid and other 
micronutrient supplementation intake were collected 
(table 2). In addition, malarial screening was performed, 
and proteinuria, glycosuria and urinary infection were 
detected using a urine dipstick test (Combi-screen; 
Figure 2 Flow chart diagram of RECIPAL study.* Study completion: follow-up from enrolment until the end of the study 
(24-month follow-up without pregnancy for women recruited before December 2014 or monthly follow-up without pregnancy for 
women recruited between December 2014 and December 2016), excluding consent withdrawal, migration and lost to follow-
up. RECIPAL, REtard de Croissance Intra-uterin et PALudisme. 
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Analyticon, Germany). Dietary intakes were assessed 
once every trimester. Five Doppler ultrasound scans 
(US) were performed. A sample of venous blood 
was collected in the first and third trimesters for Hb, 
markers of inflammation and lead levels determination.
At delivery, newborns were weighed within 1 hour 
after birth on an electronic digital scale with an accuracy 
of 2 g(SECA 757; SECA, Germany). Newborn’s length 
(SECA infantometer 416, Germany) and head circum-
ference (SECA 201, Germany) were recorded to the 
nearest millimetre. Malarial  screening was performed 
on maternal venous blood, placental and cord blood 
(table 2). A placental biopsy was performed for 
malarial histopathology. Follow-up and quality control 
Table 2 Clinical, nutritional and biological data collected during pregnancy—the RECIPAL study, 2014–2017
ANCv 1 ANCv 2 ANCv 3 ANCv 4 ANCv 5 ANCv 6 ANCv 7 ANCv8 Delivery
Clinical and nutritional data
Gestational age (weeks), mean (SD) 6.8±2.5 11.6±2.9 16.7±2.9 22.1±3.7 27.6±3.8 32.7±3.5 36.2±2.5 38.4±1.4 39.1±3.0
Medical and obstetrical history*† ‡ §  § § § § § § §
Alcohol consumption in the last 
24 hours
‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ §
Iron and folate intake in the last 
24 hours
§ ‡ ‡ ‡ ‡ ‡ ‡ ‡ §
Use of ITN the night before the visit ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ §
Axillary temperature, blood pressure ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡
Gestational age (based on LMP or 
first US)
‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡
Anthropometric measurements
  Weight ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡
  Mid-upper-arm-circumference ‡ § § ‡ § ‡ § § §
  Skinfold thickness (bicipital and 
tricipital)
‡ § § ‡ § ‡ § § §
Body composition (bioimpendance 
analysis)
‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ §
Dietary 24 hours recall § ‡ § § ‡ § ‡ § §
Biological data
Blood and rhesus group ‡ § § § § § § § §
HIV 1 screening ‡ § § § § § § § §
Peripheral malaria (TBS, PCR) ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡
Placental malaria (TBS, PCR, 
histology)
§ § § § § § § § ‡
Cord blood malaria (TBS, PCR) § § § § § § § § ‡
Hb level § ‡ § § § ‡ § § §
Serum ferritin, sTfR, CRP, AGP, folic 
acid levels
§ ‡ § § § ‡ § § §
Lead level § ‡ § § § ‡ § § §
Urinary infection and proteinuria 
(dipstick test)
‡ ‡ ‡ ‡ ‡ ‡ ‡ ‡ §
Helminthic intestinal infection (PCR) ‡ § § § § § § § §
Urinary schistosomiasis § § § § § § ‡ § §
Urine storage¶ § ‡ § ‡ § ‡ § § §
*Sickle cell disease, diabetes or other chronic medical affection; history of preterm delivery or hypertensive disorders.
†History of cigarette smoking during pregnancy collected at delivery.
‡Information collected/assessed at each specific time point.
§Information not collected/assessed at each specific time point.
¶Urine storage for further analysis.
AGP, alpha1-acid glycoprotein; ANCv, antenatal care visit; CRP, C-reactive protein; Hb, haemoglobin; ITN, insecticide-treated bed net; LMP, 
last menstrual period; RECIPAL, REtard de Croissance Intra-uterin et PALudisme; sTfR, soluble transferrin receptor; TBS, thick blood smear; 
US, ultrasound scan.
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procedures are provided in the online supplementary 
file S3.
The types and origins of the biological samples 
collected before and during pregnancy are listed in 
table 3. Total blood, serum, plasma urine samples are 
stored in −20°C or −80°C freezers with a daily monitoring 
of the temperature.
Specifics components
Malarial diagnosis
Before conception and during pregnancy, malarial screening 
was performed using both microscopy (thick blood smear) 
and PCR. Blood smears were stained with Giemsa and 
parasitaemia was quantified by the Lambaréné method.19 
A molecular diagnostic approach, using a combination of 
real-time PCR assays comprising genus-specific primers and 
probes for the gene encoding, the small (18S) Plasmodium 
rRNA and an ultrasensitive Plasmodium falciparum-specific 
detection system20 were used to screen samples containing 
Plasmodium parasites. In addition, any time during preg-
nancy, a rapid diagnostic test (Pf+pan rapid test SD Bioline 
Ag, IDA Foundation, Netherlands; BioSynex, France) was 
performed in case of symptoms suggestive of malaria for 
immediate diagnosis and treatment.
Ultrasound follow-up
The first US for dating the pregnancy was performed 
between 9 and 13 wg based on LMP recorded during the 
preconceptional follow-up (see online supplementary file 
S5). The gestational age (GA) was estimated in days based 
on crown-rump length measurement using the Robin-
son’s chart.21 At the end, GA estimation was based either 
on LMP if the difference between the two measurements 
(LMP/US) was less than 7 days or on US if the difference 
is >7 days. Following INTERGROWTH-21st methodology, 
four additional scans were performed for fetal biometry 
Table 3 Biological samples stored before conception, during pregnancy and at birth—the RECIPAL study, 2014–2017
Prepregnancy Pregnancy* Delivery/birth Planned analyses
Total blood
  Total blood (200 µL) – Mother (×2) – Erythrocytic folic acid
  Total blood (500 µL) – Mother (×2) Mother–placenta cord Metal level
  Blood spot+4°C 
(50 µL)
Mother (×1) Mother (×8)† Mother–placenta cord Plasmodium detection (PCR)
  Blood spot −20°C 
(100 µL)
Mother (×1) Mother (×8)† Mother–placenta cord Immunological markers
  Red cells (Trizol, 
100 µL)
Mother (×1) Mother (×8) Mother–placenta cord Plasmodium phenotyping
  Buffy coat PAX gene 
(300 µL)
– Mother (×2) Mother–placenta cord Immunological markers
Plasma/serum
  Plasma–20°C‡ Mother (×1) Mother (×2) Mother–placenta cord Micro-RNAs, cytokines and 
chemokines
  Plasma −80°C‡ Mother (×1) Mother (×2) Mother–placenta cord Micro-RNAs, cytokines and 
chemokines
  Serum (100 µL) Mother (×1) – Chlamydia trachomatis and 
Neisseria gonorrhoeae detection
  Serum (400 µL) – Mother (×2) Vitamin A
  Serum (100 µL)‡ Mother (×1) Mother (×2) – Ferritin, CRP, sTfR, AGP
Urine (1.8 mL) Mother (×2) Mother (×3) – Pollutant/pesticide
Stool (−80°C) Mother (×1) – – Helminthic infection
Placenta
  Biopsy with formalin – – Placenta Histopathology for malaria
  Biopsy −20°C – – Placenta Immunological markers
  Biopsy with RNA later – – Placenta Immunological markers
The frequency of sample collection is indicated in parentheses.
*During pregnancy, samples were collected twice (during the first and third trimester of pregnancy), three times (during each trimester) or eight 
times (during each ANC visit).
†In case of unscheduled visit, an additional blood spot was collected.
‡Quantity of plasma stored before, during pregnancy and at delivery was 200, 600–800, 600 µL, respectively.
AGP, alpha1-acid glycoprotein; ANC, antenatal care; CRP, C reactive protein; RECIPAL, REtard de Croissance Intra-uterin et PALudisme; 
sTfR, soluble transferrin receptor.
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assessment and uterine and umbilical blood flow measure-
ments.22 Each parameter was measured twice and then aver-
aged; a third measure was performed in case of discrepancy 
between the two first measurements. A quality control was 
performed on 10% of the pictures.
Anthropometric measurements and dietary intake assessment
Anthropometric measurements were collected using stan-
dard procedures (tables 1 and 2).23 During household 
visits, women’s body weight was measured with a 200 g preci-
sion with calibrated electronic scales (Tefal, France). At the 
facility level, women were weighed with a Tanita MC-780 
body composition device (Tanita, Tokyo, Japan). Height 
was measured to the nearest millimetre with a SECA 206 
(Hamburg, Germany) gauge. The left mid-upper-arm-cir-
cumference was measured with a SECA 201 (Hamburg, 
Germany) ergonomic circumference measuring tape. Skin-
fold thickness measurements were made to the nearest 
millimetre at the triceps and biceps sites using a Holtain 
(Crymyeh, UK) skinfold calliper. The set of measurements 
was repeated twice—by the same field investigator—and 
then the measurements were averaged. Body composition, 
assessed by bioelectrical impedance analysis method, was 
measured by the multifrequency body composition anal-
yser Tanita MC-780 with a four-electrode arrangement 
paired on hands and feet. A quality control of anthropo-
metric data was performed periodically by a senior research 
scientist in nutrition.
Dietary intakes were assessed by 24-hour recalls using the 
standard multiple-pass methodology.24 A comprehensive 
list of the most common food items and recipes was devel-
oped from a preliminary study of the diet habits of the study 
area. This list was used to identify foods mentioned by the 
women as consumed during the interview. Amounts of food 
consumed were estimated by household measures consisted 
of precalibrated utensils, food pictures of different portion 
sizes and monetary value of known food portions sold 
on the study area markets. A food composition table and 
recipes database are under construction for conversion of 
household units to gram and to determine macronutrients 
and micronutrients intake by the women.
Characteristics of the study populations
At enrolment, WRA were 27 years old in average (table 4). 
Nulligravidae represented 8.8% of the cohort. More than 
half of the women were anaemic, one quarter was infected 
with schistosomiasis and 38% had an abnormal body mass 
index. The prevalence of microscopic malaria was 5.7%, 
with two geographical clusters in Sô-Ava and Vekky subdis-
tricts (figure 3). The median duration of follow-up in the 
initial cohort was 5.9 months (mean=7.1, range: 0.49–23.7). 
Compared with women included in the initial cohort, 
women who did not complete the follow-up were signifi-
cantly different in terms of residence area, ethnicity, house-
hold density and schistosomiasis status (table 4).
Pregnant women were identified at a mean of 6.9 wg 
and benefited from 7.5 scheduled ANC visits in average 
(table 4). The prevalence of microscopic malarial infection 
was 25.4%, 19.4% and 16.1% during the first, second and 
third trimester of pregnancy, respectively. The prevalence 
of SGA was 11.5% and 18.3% using Schmiegelow’s and 
INTERGROWTH-21st charts, respectively (table 5). The 
proportion of PTB and LBW was 12.6% and 9.3%, respec-
tively. Overall, 29.5% (61/207) of newborns presented at 
least one poor birth outcome defined as LBW, PTB, SGA 
or stillbirth.
FIndIngs to dAte
Fertility and time to pregnancy
The median time to pregnancy was 12.3 months (figure 4). 
The fertility rate was 5.4 pregnancies/100 persons-
month (95% CI =4.9 to 5.9). The probability (95% CI) of 
conceiving after 5, 10, 15 and 20 months of follow-up were 
24.5% (21.9–27.4), 42.1% (38.6–45.9), 56.6% (52.1–61.1) 
and 62.8% (57.6–68), respectively. Using multivariate 
survival analysis, factors associated with a lower risk of 
conceiving were maternal age more than 35 years, a low 
education level, being polygamous, living in Vekky subdis-
trict, long-term couple (>8 years), infrequent sexual activity, 
overweight and urinary schistosomiasis infection (E Yovo, 
personal communication, 2017).
Malaria in the first trimester of pregnancy
The incidence rate of malarial infection during the first 
trimester was 19.7 cases per 100 persons-month (95% CI 
15.8 to 24.5). Using a multilevel logistic regression, we 
showed that women infected with malaria before concep-
tion were more likely to be infected during the first 
trimester (adjusted OR (aOR): 2.68, 95% CI 1.24 to 5.78). 
Gestational age was also negatively correlated with malarial 
infection (aOR: 0.64, 95% CI 0.41 to 0.98) (M Accrombessi, 
personal communication, 2017).
strengths And lIMItAtIons
The preconceptional design—and early identification of 
pregnant women—allowed (1) the screening of women 
for malaria from the very beginning of pregnancy; (2) the 
accurate estimation of GA by using US before 14 wg; (3) 
the determination of prepregnancy nutritional status25 
and hypertensive disorders screening,26 which highly 
influence fetal growth and (4) the minimisation of selec-
tion bias embedded in the design of women recruited 
at facility level. Besides, PTB and intrauterine growth 
restriction could be accurately assessed thanks to the 
precise estimation of GA and longitudinal fetal growth 
assessment.
In addition to malaria, RECIPAL will provide valuable 
information on WRA in Africa in terms of fertility and 
nutrition, which are seldom evaluated and may help to 
define new preconceptional interventions for improving 
maternal and child health.27 Also, it yields logistical and 
ethical information for the implementation of future 
preconceptional cohorts.
Tropical M
edicine. Protected by copyright.
 o
n
 N
ovem
ber 20, 2019 at London School of Hygiene and
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019014 on 8 January 2018. Downloaded from 
 9Accrombessi M, et al. BMJ Open 2018;8:e019014. doi:10.1136/bmjopen-2017-019014
Open Access
Table 4 Characteristics of women included in the initial and final RECIPAL cohorts, Southern Benin, 2014–2017
Characteristics
Initial cohort 
(n=1214 WRA)
WRA with 
incomplete 
follow-up 
(n=444)
P value
(1214 vs 
444)*
WRA with 
complete 
follow-up but 
no pregnancy 
(n=359)
Final cohort
Pregnant 
women
(n=411)
P value
(411 vs 359)*
General 
characteristics
  Subdistrict, n (%) Sô–Ava 279 (23.0) 102 (23.0) 45 (12.5) 132 (32.1)
Vekky 423 (34.8) 228 (51.4) <0.001 57 (15.9) 138 (33.8) <0.001
Houedo 186 (15.3) 33 (7.4) 120 (33.4) 33 (7.8)
Akassato 326 (26.9) 81 (18.2) 137 (38.2) 108 (26.3)
  Ethnic group, n (%) Toffin 864 (71.2) 346 (77.9) 218 (60.7) 300 (72.9)
Aizo 195 (16.1) 56 (12.6) 0.001 80 (22.3) 59 (14.4) 0.002
Fon 86 (7.1) 23 (5.2) 31 (8.6) 32 (7.8)
Others 69 (5.6) 19 (4.3) 30 (8.4) 20 (4.9)
  Age (years) Mean (±SD) 27.8 (±5.5) 28.0 (±5.6) 0.31 28.8 (±5.6) 26.8 (±5.0) <0.001
  Marital status, n (%) Polygamy 445 (36.7) 173 (38.9) 154 (42.9) 118 (28.7)
Monogamy 729 (60.0) 257 (57.9) 0.45 204 (56.8) 268 (65.2) <0.001
Cohabitation 40 (3.3) 14 (3.1) 1 (0.3) 25 (6.1)
  Education, n (%) Illiterate 889 (73.2) 336 (75.7) 0.14 263 (73.3) 290 (70.6) 0.41
  Household density Mean (±SD) 5.7 (±3.0) 6.0 (±3.4) 0.009 5.2 (±2.3) 5.9 (±3.0) 0.001
  Gravidity, n (%) Nulligravidae 107 (8.8) 48 (10.8) 26 (7.2) –
Primigravidae 167 (13.8) 58 (13.1) 0.17 43 (12.0) 33 (8.0) 0.22
Multigravidae 940 (77.4) 338 (76.1) 290 (80.8) 378 (92.0)
  Number of live 
birth(s)
Mean (±SD) 2.8 (±2.0) 2.6 (±2.0) 0.07 2.9 (±2.1) 2.7 (±1.9) 0.16
  Short stature, n (%) Maternal 
length <150 cm
92 (8.0) 27 (6.1) 0.46 32 (8.9) 33 (8.0) 0.65
  Mid-upper-arm-
circumference, n 
(%)
<23 cm 76 (6.3) 23 (5.2) 0.62 27 (7.5) 26 (6.3) 0.51
Preconceptional
characteristics
  BMI, n (%) <18.5 kg/m² 95 (8.3) 26 (6.9) 29 (8.1) 40 (9.7)
18.5‒24 kg/m² 706 (61.7) 229 (61.1) 0.36 212 (59.2) 265 (64.5) 0.10
≥25 kg/m² 343 (30.0) 120 (32.0) 117 (32.7) 106 (25.8)
  Schistosomiasis 
infection, n (%)†
Yes 177 (24.7) 50 (31.2) 0.03 63 (19.6) 64 (27.0) 0.04
  Anaemia, n (%)‡ Yes 596 (49.1) 210 (47.3) 0.07 165 (46.0) 221 (53.8) 0.03
  Microscopic 
malaria, n (%)§
Yes 64 (5.7) 28 (7.5) 0.06 12 (3.4) 24 (5.9) 0.10
Gestational 
characteristics
  Median time to 
pregnancy (months)
Median – – – – 12.3 –
  Fertility incidence 
rate (95% CI)
– – – – 5.4 (4.9–5.9) –
  Gestational age 
at first ANC visit 
(weeks)
Mean (±SD) – – – — 6.9 (±2.5) –
Continued
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Only 107 (8%) nulligravidae were included in the study. 
The main reason is that RECIPAL was implemented shortly 
after a study, which has recruited nulligravid WRAs living 
in the same area. This study aimed at assessing maternal 
immune responses in early pregnancy to help designing 
a phase 1 vaccine trial against malaria. It included 278 
Characteristics
Initial cohort 
(n=1214 WRA)
WRA with 
incomplete 
follow-up 
(n=444)
P value
(1214 vs 
444)*
WRA with 
complete 
follow-up but 
no pregnancy 
(n=359)
Final cohort
Pregnant 
women
(n=411)
P value
(411 vs 359)*
  Gravidity, n (%) Primigravidae – – – – 33 (8.0) –
Multigravidae – – – – 378 (92.0)
  Number of IPTp 
doses, n (%)**
≥2 – – – – 136 (65.7) –
  Inadequate 
gestational weight 
gain†, n (%)**
Yes – – – – 120 (57.9) –
  Number of ANC 
visits (scheduled)**
Mean (±SD) – – – – 7.5 (±1.1) –
  Number of 
ANC visits 
(unscheduled)**
Mean (±SD) – – – – 2.1 (±1.3) –
  HIV status, n (%)** Positive – – – – 4 (1.9) –
  Gestational 
hypertension, n 
(%)**
Yes – – – – 7 (3.4) –
  Anaemia, n (%)‡** During 
pregnancy‡‡
– – – – 142 (68.6) –
In the first 
trimester
– – – – 98 (48.5) –
In the third 
trimester
– – – – 118 (57.0) –
  Microscopic 
malaria, n (%)**
During 
pregnancy‡‡
– – – – 93 (44.9) –
In the first 
trimester ‡‡
– – – – 51 (25.4) –
In the second 
trimester‡‡
– – – – 40 (19.4) –
In the third 
trimester‡‡
– – – – 33 (16.1) –
  Placental malarial 
infection, n (%)**
Yes – – – – 13 (7.8) –
*Student’s  t-test and χ2 test were used for comparing continuous and categorical variables, respectively. 
†Schistosomiasis infection status before conception has been assessed in 718 WRA (initial cohort): 160 with incomplete preconceptional 
follow-up, 321 with complete preconceptional follow-up without pregnancy and 237 included in the final cohort.
‡According to WHO thresholds (12 g/dL for non-pregnant women and 11 g/dL for pregnant). 
§Before conception, 78 missing and 5 missing values in the initial and final cohort, respectively. During pregnancy, 6, 1 and 2 missing values 
at first, second and third trimester of pregnancy, respectively; 40 missing values for placental malaria. 
¶Incidence rate defined as the number of pregnancies/persons-month at risk. 
**Results based on the 207 women who have already delivered. 
††A gestational weight gain was considered inadequate when the total weight gain during pregnancy was below to 12.5 kg, 11.5 kg, 7 kg 
and 5 kg in the underweight women (prepregnancy BMI < 18.5 kg/m²), normal weighted women (prepregnancy BMI between 18.5 and 24.9 
kg/m²), overweight women (prepregnancy BMI between 25.0 and 29.9 kg/m²) and obese women (prepregnancy BMI ≥30 kg/m²) before 
conception, respectively. 
‡‡ At least one episode. 
ANC, antenatal care; BMI, body mass index; IPTp, intermittent preventive treatment in pregnancy; RECIPAL, REtard de Croissance Intra-
uterin et PALudisme; WRA, women of reproductive age.
Table 4 Continued 
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nulligravid WRAs, of whom 60 became pregnant.28 Both 
studies were conducted concomitantly for several months 
and women already included in the first study could not 
be eligible for RECIPAL. Because primigravidae were 
under-represented in the final RECIPAL cohort, it is 
likely that the prevalence of maternal conditions related 
to primigravidity were underestimated. Although we 
cannot completely exclude selection bias, it should not 
have strongly influenced the association between malaria 
in early pregnancy and FGR.
Finally, because of constraints related to the study design 
(long duration of the preconceptional follow-up and 
weariness of the women) and African sociocultural reali-
ties (rumour about blood collection, suspicion regarding 
medical care provided free of charge, etc), a noticeable 
proportion (22%) of women withdrew their informed 
consent before the end of the 24-month follow-up. 
Overall, the initial cohort attrition was 37%. Since some 
baseline characteristics in women who completed the 
preconceptional follow-up and those who did not were 
different, this might impact the external validity of some 
of results. During pregnancy, there was a high proportion 
(16.5%) of spontaneous abortions, which contributed 
to the final cohort attrition. At the end, birth outcomes 
Figure 3 Malarial status (infected vs non-infected) in 
women of reproductive age at inclusion in RECIPAL (initial 
cohort), Southern Benin, 2014–2017. For online interactive 
map, check this link: Malaria Infection Status of Women at 
Inclusion of Cohort. RECIPAL, REtard de Croissance Intra-
uterin et PALudisme. 
Table 5 Preliminary data description of newborns at birth (subsample of the cohort)—the RECIPAL study (2014–2017)
Newborn characteristics* n Mean (±SD) or proportion (%)
Gender Male 205 55.2
Stillbirth Per 1000 live births 206 14.8
Preterm birth (<37 weeks) Yes 207 12.6
Small birth weight for gestational age †‡§ Yes 191 11.5
Small birth weight for gestational age‡§ Yes 191 18.3
Birth weight (g)‡ 193 3043.9 (±432.8)
<2500 193 9.3
Poor birth outcome‡¶ Yes 207 29.5
*Data based on the first 207 deliveries.
†Small birth weight for gestational age: <10th percentile of birth weight for gestational age using Schmiegelow’s charts.
‡Twins excluded.
§Small birth weight for gestational age: <10th percentile of birth weight for gestational age using INTERGROWTH-21st charts.
¶Stillbirth, preterm birth, small birth weight for gestational age (using INTERGROWTH-21st charts) or low birth weight.
RECIPAL, REtard de Croissance Intra-uterin et PALudisme.
Figure 4 Kaplan-Meier failure estimate of the probability 
of conceiving; 1214 women of reproductive age 
included in the initial RECIPAL cohort, Southern Benin, 
2014–2017. Probability of conceiving (solid line) and its 
95% CI (grey lines). Number of pregnancy events are 
in parentheses. Number of censored women at 5, 10, 
15, 20 and 24 months were 223, 260, 88, 50 and 30, 
respectively. RECIPAL, REtard de Croissance Intra-uterin et 
PALudisme. 
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could be evaluated in only 68% of women, with a possible 
lack of power for some upcoming analyses.
ConClusIon
If the deleterious effects of malaria in the first trimester 
of pregnancy are confirmed, our results may argue in 
favour of starting preventive measures from the very 
beginning of pregnancy or even before pregnancy. Arte-
misinin-based combination therapies have been shown to 
be safe during the first trimester of pregnancy and, there-
fore, may be a good option for the replacement of SP.29 
Besides, a vaccine against pregnancy-associated malarial 
parasites, which could elicit protective immunity prior to 
pregnancy to best protect pregnant women during early 
pregnancy may be proposed as a complementary strategy. 
Such a vaccine is currently under evaluation.30
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